Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older

Background: In elderly individuals aged ≥65 years with hepatitis C virus (HCV) infection, efficacious and safe HCV therapy is complicated by frequent comorbidities and concomitant medications. The aim of this analysis was to evaluate the efficacy and safety of elbasvir/grazoprevir (EBR/GZR) in peopl...

Descripción completa

Detalles Bibliográficos
Autores principales: Flamm, Steven, Peng, Cheng-Yuan, Shibolet, Oren, Nahass, Ronald, Hwang, Peggy, Barr, Eliav, Robertson, Michael N., Haber, Barbara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415929/
https://www.ncbi.nlm.nih.gov/pubmed/30891470
http://dx.doi.org/10.1177/2333721418817398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415929/
https://www.ncbi.nlm.nih.gov/pubmed/30891470
http://dx.doi.org/10.1177/2333721418817398

Ejemplares similares